Skip to content

Agilon Health AGL Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax

Other financials

Income statement

See full
Revenue$1.4B-7.3%
Operating income$4.0M+118%
Net income$48.9M+304%
EPS (diluted)$2.94+303%

Balance sheet

See full
Cash & equivalents$211.6M+52.6%
Total debt$33.4M-20.5%
Total equity$181.4M-63.7%
Total assets$1.5B-22.1%

Cash flow

See full
Operating cash flow$23.7M+174%
CapEx$3.1M-19.4%
Free cash flow$20.6M+158%

Valuation

See full
Market cap$1.78B-92.6%
Enterprise value$1.61B-103%
P/S0.3×-3.8×

Profitability

See full
Operating margin-7.5%+6.5pp
Net margin-6.1%+6.3pp
FCF margin-1.1%

Returns & leverage

See full
Return on equity-104%-291pp
Debt / equity0.2×+0.1×
Current ratio-0.2×

Where this comes from

Reported directly by Agilon Health in its filing.

Tagged under the XBRL concept us-gaap:DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax.

The official record: Agilon Health’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Agilon Health's discontinued operation gain loss on disposal of discontinued operation net of tax.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Agilon Health's discontinued operation gain loss on disposal of discontinued operation net of tax?
Agilon Health (AGL) reported discontinued operation gain loss on disposal of discontinued operation net of tax of $19M in Q1 2026.
How has Agilon Health's discontinued operation gain loss on disposal of discontinued operation net of tax changed year-over-year?
Agilon Health's discontinued operation gain loss on disposal of discontinued operation net of tax increased by 35.7% year-over-year, from $14M to $19M.